Ace Ltd (ACE) 111.02 $ACE Neo Telemedia Announces 2016

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ace Ltd (ACE) 111.02 $ACE

Neo Telemedia Announces 2016 First Quarter Results
JCN Newswire - Thu May 12, 10:04AM CDT

ACE: 111.02 (+0.96)

A.M. Best Special Report: U.S. Property/Casualty Insurers' Stock Prices End 2015 on Upswing Despite Market Turbulence
BusinessWire - Tue Apr 12, 2:44PM CDT
Stocks of U.S. property/casualty (P/C) insurance companies fared better in fourth-quarter 2015 after a tumultuous third quarter that saw the worst U.S. equity market performance in years, according to a new A.M. Best special report.
ACE: 111.02 (+0.96)

Fitch: D&O Insurance Pricing Pressure to Dampen Performance
BusinessWire - Tue Apr 12, 2:04PM CDT
Market conditions are evolving in the U.S. directors and officers (D&O) liability insurance market. Merger and acquisition (M&A) activity in 2015 has facilitated greater market concentration, and pricing pressure will likely challenge profitability going forward, according to a new report from Fitch Ratings.
ACE: 111.02 (+0.96), AIG: 53.86 (+0.57)

Fitch Affirms ACE Ltd & Chubb's IFS Ratings Following Acquisition; Downgrades Chubb Holding Company
BusinessWire - Fri Jan 15, 8:59AM CST
Fitch Ratings has affirmed all the ratings for ACE Limited and its subsidiaries (ACE) and the Insurer Financial Strength (IFS) ratings for The Chubb Corporation (Chubb) operating subsidiaries. Fitch has downgraded Chubb's Issuer Default Rating (IDR) to 'A+' from 'AA-' and downgraded all other holding company obligations one notch. The Rating Outlook for all ratings is Stable. A complete list of ratings follows at the end of this release.
ACE: 111.02 (+0.96)

ACE Completes Acquisition of Chubb; Adopts Chubb Name and Launches New Chubb Brand
PR Newswire - Thu Jan 14, 5:03PM CST
ACE Limited (NYSE: ACE) announced today that it has completed its acquisition of Chubb, creating the world's largest publicly traded property and casualty insurance company. ACE paid approximately $29.5 billion in the aggregate in cash and stock, based on the most recent closing price of ACE Limited shares and the number of outstanding shares of The Chubb Corporation common stock at the time of closing. Effective immediately, ACE is adopting the Chubb name globally and the company will begin trading tomorrow on the New York Stock Exchange under the symbol "CB." The company is also formally launching the new Chubb brand, including its visual identity and "signature." The new Chubb brand stands for superior underwriting, service and execution - attributes shared by both ACE and Chubb.
ACE: 111.02 (+0.96), CB: 129.64 (-0.31)

ACE Limited Sees Value Creation with Chubb Corp Addition
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 3:00PM CST
On Jan 14, we issued an updated research report on ACE Limited (ACE).
ACE: 111.02 (+0.96), PRE: 140.52 (+0.04), RNR: 115.65 (-0.17), UVE: 19.61 (+0.66)

Extra Space Storage Set to Join the S&P 500; EPR Properties to Join S&P MidCap 400; U.S. Concrete, World Wrestling Entertainment to Join S&P SmallCap 600
PR Newswire - Wed Jan 13, 4:44PM CST
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
ACE: 111.02 (+0.96), WWE: 20.09 (-0.37), CB: 129.64 (-0.31), EXR: 93.49 (-0.18), WPP: 10.24 (unch), MHFI: 107.92 (+1.16), EPR: 80.69 (-0.34), USCR: 64.09 (+2.03)

ACE Acquisition of Chubb is Expected to Close on January 14
PR Newswire - Wed Jan 13, 11:33AM CST
The Chubb Corporation (NYSE: CB) announced today that all regulatory approvals needed for its acquisition by ACE Limited have been received and that the transaction is expected to close on January 14, 2016, pending satisfaction of remaining customary closing requirements.
ACE: 111.02 (+0.96), CB: 129.64 (-0.31)

ACE Receives All Regulatory Approvals Needed to Close Acquisition of Chubb
PR Newswire - Wed Jan 13, 11:00AM CST
ACE Limited (NYSE: ACE) announced that it has received all regulatory approvals needed for closing its acquisition of Chubb, a transaction that will create the world's largest publicly traded property and casualty insurer. The acquisition, announced on July 1, 2015 and valued at approximately $29.7 billion, based on the closing price of ACE Limited shares and the number of outstanding shares of Chubb common stock on January 12, 2016, is expected to close on Thursday, January 14, 2016, pending satisfaction of remaining customary closing requirements. As previously announced, ACE will adopt the Chubb name upon closing and the company's stock will begin trading on the New York Stock Exchange under the symbol CB on the first trading day following the closing.
ACE: 111.02 (+0.96)

Upgrade Alert for ACE (ACE)
Comtex SmarTrend(R) - Wed Jan 13, 8:22AM CST
ACE (NYSE:ACE) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $112.10 on volume of 2.9 million shares, above average daily volume of 2.2 million. Potential upside of 9.6% exists for ACE, based on a current level of $112.10 and analysts' average consensus price target of $122.81. The stock should hit resistance at its 50-day moving average (MA) of $114.72, as well as support at its 200-day MA of $108.63.
ACE: 111.02 (+0.96)

Chubb Expects Fourth Quarter Financial Results To Be Announced On January 26
PR Newswire - Fri Jan 08, 8:00AM CST
The Chubb Corporation (NYSE: CB) expects that its fourth quarter 2015 financial results will be announced on Tuesday, January 26, 2016 after the close of the market. The press release and financial supplement will be available shortly thereafter on Chubb's website at www.chubb.com.
ACE: 111.02 (+0.96), CB: 129.64 (-0.31)

ACE to Hold its Fourth Quarter Earnings Conference Call on Wednesday, January 27, 2016
BusinessWire - Fri Jan 08, 8:00AM CST
ACE Limited (NYSE: ACE) will hold its fourth quarter earnings conference call on Wednesday, January 27, 2016, beginning at 8:30 a.m. Eastern.
ACE: 111.02 (+0.96)

Watch for ACE to Potentially Rebound After Falling 1.86% Yesterday
Comtex SmarTrend(R) - Wed Jan 06, 5:46PM CST
ACE (NYSE:ACE) traded in a range yesterday that spanned from a low of $112.23 to a high of $113.84. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $112.52 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ACE: 111.02 (+0.96)

ACE Falls 1.86% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jan 06, 5:46PM CST
ACE (NYSE:ACE) traded in a range yesterday that spanned from a low of $112.23 to a high of $113.84. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $112.52 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ACE: 111.02 (+0.96)

When Minutes Matter: New ESIS Mobile Application Speeds Access to Critical Construction Risk Management Resources
BusinessWire - Wed Jan 06, 8:00AM CST
When accidents happen on a construction site, response time is critical. Reporting the incident quickly and initiating a rapid response may help mitigate claim severity and associated loss costs. To assist clients in the aftermath of a construction accident, ESIS, Inc. (ESIS(R)), - a risk management services company and member of ACE Group - has introduced ESIS On Call for Construction, a proprietary rapid response tool for severe workers compensation or complex automobile and general liability insurance claims.
ACE: 111.02 (+0.96)

Watch for ACE to Potentially Pullback After Gaining 1.02% Yesterday
Comtex SmarTrend(R) - Tue Dec 29, 6:24PM CST
ACE (NYSE:ACE) traded in a range yesterday that spanned from a low of $117.77 to a high of $119.54. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $118.78 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ACE: 111.02 (+0.96)

ACE Set to Possibly Pullback After Yesterday's Rally of 1.02%
Comtex SmarTrend(R) - Tue Dec 29, 6:24PM CST
ACE (NYSE:ACE) traded in a range yesterday that spanned from a low of $117.77 to a high of $119.54. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $118.78 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ACE: 111.02 (+0.96)

ACE Announces Two Senior Leadership Appointments for Europe
BusinessWire - Thu Dec 24, 4:37AM CST
ACE Group today announced two appointments within its European management team, with immediate effect.
ACE: 111.02 (+0.96)

After Yesterday's Rally of 1.73% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Dec 22, 4:24PM CST
ACE (NYSE:ACE) traded in a range yesterday that spanned from a low of $115.47 to a high of $117.44. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $117.16 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ACE: 111.02 (+0.96)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading